Biogen Inc.
BIIBLast close · Oct 16, 2026232.65−2.70 (−1.15%)
Market cap$34.4B
Key indicators
Revenue9.9B+1.2% on a year earlier
13.5B
14.4B
13.4B
11.0B
10.2B
9.8B
9.7B
9.9B
9.9B
10.5B
10.7B
11.0B
Fiscal year
FY201818
FY201919
FY202020
FY202121
FY202222
FY202323
FY202424
FY202525
TTMTTM
FY2026E26E
FY2027E27E
FY2028E28E
| Fiscal year | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | FY2026E | FY2027E | FY2028E |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||||||
| 13.5B | 14.4B+6.9% | 13.4B−6.5% | 11.0B−18.3% | 10.2B−7.4% | 9.8B−3.3% | 9.7B−1.6% | 9.9B+2.2% | 9.9B+1.2% | 10.5B | 10.7B | 11.0B | |
| — | 6.9% | -6.5% | -18.3% | -7.4% | -3.3% | -1.6% | 2.2% | 1.2% | 5.7% | 2.1% | 3.0% | |
| $21.58 | $31.42+45.6% | $24.80−21.1% | $10.40−58.1% | $20.87+100.7% | $7.97−61.8% | $11.18+40.3% | $8.79−21.4% | $9.30−8.2% | $12.42 | $16.50 | $18.62 | |
| Profitability | ||||||||||||
| 86.5% | 86.4%−0.1 pt | 86.6%+0.2 pt | — | — | — | — | — | — | · | · | · | |
| 43.8% | 49.0%+5.2 pt | 33.8%−15.1 pt | 25.9%−8.0 pt | — | — | — | — | — | · | · | · | |
| 32.9% | 41.0%+8.0 pt | 29.8%−11.2 pt | 14.2%−15.6 pt | 29.9%+15.8 pt | 11.8%−18.1 pt | 16.9%+5.1 pt | 13.1%−3.8 pt | 13.8%−1.3 pt | · | · | · | |
| 34.0% | 44.1%+10.2 pt | 37.4%−6.7 pt | 14.3%−23.1 pt | 22.7%+8.5 pt | 7.8%−14.9 pt | — | — | — | · | · | · | |
| Cash | ||||||||||||
| 5.4B | 6.6B+21.2% | 3.8B−42.0% | 3.4B−11.1% | 1.1B−66.2% | 1.3B+11.0% | 2.7B+114.3% | 2.1B−24.7% | 2.4B−0.6% | · | · | · | |
| 40.3% | 45.7%+5.4 pt | 28.3%−17.4 pt | 30.8%+2.5 pt | 11.2%−19.5 pt | 12.9%+1.7 pt | 28.1%+15.2 pt | 20.7%−7.4 pt | 24.4%−0.4 pt | · | · | · | |
| Balance sheet | ||||||||||||
| 0.46x | 0.56x+0.10x | 0.70x+0.14x | 0.79x+0.09x | 0.49x−0.30x | 0.47x−0.02x | — | — | — | · | · | · | |
| 205.30M | 187.40M−8.7% | 161.30M−13.9% | 149.60M−7.3% | 146.00M−2.4% | 145.60M−0.3% | 145.90M+0.2% | 147.10M+0.8% | 148.40M+1.2% | · | · | · | |
E = analyst consensus (revenue and EPS only). TTM = the twelve months to Mar 31, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.